Kolon TissueGene Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5,159	5,073	3,706	9,456	4,003
Revenue Growth (YoY)	1.68%	36.90%	-60.81%	136.22%	12.58%
Cost of Revenue	4,544	4,528	3,340	1,811	3,611
Gross Profit	614.5	545.13	365.92	7,645	392.15
Selling, General & Admin	13,343	15,849	13,679	14,694	15,906
Research & Development	8,549	5,612	5,635	7,123	29,890
Amortization of Goodwill & Intangibles	29.7	39.95	113.74	98.19	87.7
Other Operating Expenses	237.61	269.39	173.93	224.81	56.02
Operating Expenses	22,938	22,543	20,877	23,953	47,493
Operating Income	-22,323	-21,998	-20,511	-16,308	-47,101
Interest Expense	-89.6	-89.85	-285.82	-371.18	-466.46
Interest & Investment Income	1,760	1,040	2,221	670.49	129.69
Currency Exchange Gain (Loss)	787.43	813.15	256.82	1,512	50.89
Other Non Operating Income (Expenses)	-172,739	-13,661	1,351	4,676	249.99
EBT Excluding Unusual Items	-192,604	-33,895	-16,968	-9,821	-47,136
Gain (Loss) on Sale of Assets	37.35	1.02	-3.43	-	-14.87
Pretax Income	-192,567	-33,894	-16,971	-9,821	-47,151
Income Tax Expense	20.94	-95.47	253.15	1,316	218.27
Net Income	-192,587	-33,799	-17,224	-11,136	-47,370
Net Income to Common	-192,587	-33,799	-17,224	-11,136	-47,370
Shares Outstanding (Basic)	82	77	72	66	61
Shares Outstanding (Diluted)	82	77	72	66	61
Shares Change (YoY)	6.78%	7.32%	8.18%	8.25%	0.29%
EPS (Basic)	-2343.80	-439.20	-240.20	-168.00	-773.60
EPS (Diluted)	-2343.80	-439.20	-240.20	-168.00	-773.60
Free Cash Flow	-25,210	-20,581	-24,370	-26,844	-40,568
Free Cash Flow Per Share	-306.81	-267.44	-339.84	-404.97	-662.52
Gross Margin	11.91%	10.75%	9.87%	80.85%	9.80%
Operating Margin	-432.73%	-433.58%	-553.45%	-172.46%	-1176.59%
Profit Margin	-3733.25%	-666.19%	-464.76%	-117.77%	-1183.31%
Free Cash Flow Margin	-488.69%	-405.66%	-657.56%	-283.88%	-1013.40%
EBITDA	-21,539	-21,189	-19,099	-14,643	-45,550
EBITDA Margin	-	-	-	-154.85%	-
D&A For EBITDA	784.02	808.55	1,412	1,665	1,551
EBIT	-22,323	-21,998	-20,511	-16,308	-47,101
EBIT Margin	-	-	-	-172.46%	-
Advertising Expenses	19.35	37.32	11.48	0.5	18.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.